Biomarker Therapy in 2025: More Lung Cancer Options, Competition in New Drug Classes, ctDNA Advances
This year, there was a surge of new lung cancer treatments, more options for patients with earlier-stage disease, and growing ...
Lung cancer in never-smokers exhibits distinct biological characteristics, often leading to late-stage diagnoses due to lack of screening. Targeted therapies, guided by molecular testing, offer ...
Each type of cancer is unique, and there’s no one-size-fits-all treatment. Immunotherapy and targeted medications allow doctors to treat cancer using different approaches that help improve overall ...
Explore the latest advancements in oncology, including biomarkers and targeted therapies, enhancing patient care at Tennessee Oncology and Vanderbilt-Ingram Cancer Center. Cancer treatment has evolved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results